Paul E. Oberstein
Impact in
- Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research
- COVID-19 and healthcare impacts
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Oncology 41
- Pancreatic and Hepatic Oncology Research 34
- Cancer Immunotherapy and Biomarkers 4
- Colorectal Cancer Treatments and Studies 2
-
- Oral microbiology and periodontitis research 3
- Co-authors
- Kenneth P. Olive (6 shared papers)Carmine F. Palermo (3 shared papers)Stephen A. Sastra (3 shared papers)Tyler Saunders (1 shared paper)Emily T. Mirek (1 shared paper)Martín E. Fernández-Zapico (1 shared paper)Dafydd Thomas (1 shared paper)Ian Tattersall (1 shared paper)
- Journals
- Journal of Clinical Oncology (7 papers)Clinical Cancer Research (4 papers)The Oncologist (4 papers)Annals of Oncology (2 papers)JAMA Oncology (2 papers)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Paul E. Oberstein
53 papers receiving 5.8k citations
Paul E. Oberstein's Hit Papers
Peers
Comparison fields: 5 of 106
- Oncology 3.9k
- Infectious Diseases 520
- Cell Biology 285
- Cancer Research 264
- Biomaterials 193
Countries citing papers authored by Paul E. Oberstein
This map shows the geographic impact of Paul E. Oberstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul E. Oberstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul E. Oberstein more than expected).
Fields of papers citing papers by Paul E. Oberstein
This network shows the impact of papers produced by Paul E. Oberstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul E. Oberstein. The network helps show where Paul E. Oberstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul E. Oberstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma Hit paper breakdown → | 2014 | 1742 |
| 2 | Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study Hit paper breakdown → | 2020 | 1348 |
| 3 | 2017 | 415 | |
| 4 | Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma Hit paper breakdown → | 2020 | 385 |
| 5 | 2018 | 266 | |
| 6 | 2013 | 261 | |
| 7 | 2019 | 217 | |
| 8 | Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment Hit paper breakdown → | 2023 | 176 |
| 9 | 2019 | 159 | |
| 10 | 2017 | 121 | |
| 11 | 2022 | 104 | |
| 12 | 2021 | 80 | |
| 13 | 2017 | 70 | |
| 14 | 2020 | 48 | |
| 15 | 2022 | 45 | |
| 16 | 2018 | 40 | |
| 17 | First-line treatment for advanced pancreatic cancer. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011. | 2011 | 37 |
| 18 | 2019 | 36 | |
| 19 | 2024 | 30 | |
| 20 | 2012 | 21 |
About Paul E. Oberstein
Paul E. Oberstein is a scholar working on Oncology, Periodontics, Epidemiology, Pulmonary and Respiratory Medicine and Psychiatry and Mental health, having authored 58 papers that have together received 5.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (34 papers), Neuroendocrine Tumor Research Advances (7 papers), Cancer Immunotherapy and Biomarkers (4 papers), Oral microbiology and periodontitis research (3 papers), Esophageal Cancer Research and Treatment (2 papers), Ultrasound Imaging and Elastography (2 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (3.9k citations), Infectious Diseases (520 citations), Cell Biology (285 citations), Cancer Research (264 citations) and Biomaterials (193 citations). Paul E. Oberstein has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Kenneth P. Olive, Carmine F. Palermo, Stephen A. Sastra, Tyler Saunders, Emily T. Mirek, Martín E. Fernández-Zapico, Dafydd Thomas, Ian Tattersall, Jan Kitajewski and Andrew D. Rhim. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, The Oncologist, Annals of Oncology and JAMA Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.